K
Kymab
0 followers
Kymab is a clinical-stage global biopharmaceutical company focused on the discovery and development of fully human monoclonal antibody drugs using its proprietary antibody platform which contains a full diversity of human antibodies, making it the most comprehensive antibody development platform ava... Read more
Org chart
Simon Sturge
CEO
Simon Sturge
Collapse
Allan Bradley
Chief Scientific Officer
Anne Hyland
CFO
Nigel Clark
SVP, Business Development
Jasper Clube
SVP, Intellectual Property & Chief Patent Counsel
David Melvin
VP of Informatics
Richard Williams
Vice President CMC
Board & advisors
Martin Nicklasson
Non-Executive Chair
Erwin Boos
Director
Jean-Michel Cosséry
Director
Tan Li
Non-Executive Director
Catherine Moukheibir
Non-Executive Director
Timothy Wells
Non-Executive Director
Simone Song
Non-Executive Director
Timothy J Rink
Non-Executive Director
Christian Itin
Non-Executive Director
David Chiswell
Scientific Advisor
George Demetri
Advisor
Douglas T Fearon
Advisor
Stephen D. Gillies
Advisor
Neil H Segal
Advisor
Kenneth Smith
Advisor
Mark Smyth
Advisor
Alexander Drakesmith
Advisor
Iain MacDougall
Advisor
Dorine Swinkels
Advisor
Günter Weiss
Advisor
Sergio Quezada
Advisor
Teams
Offices
Similar companies
QuellTX
4 followers
Halozyme Therapeutics
6 followers
Biofourmis
6 followers
Immunovant
6 followers
C4 Therapeutics
5 followers
Summit Therapeutics
5 followers
Stemline Therapeutics
3 followers
Mesoblast
3 followers
Arcturus Therapeutics
2 followers
Tenaya Therapeutics
2 followers
Scipher Medicine
2 followers
Explore companies